Cutaneous CD56+ large T-cell lymphoma associated with high serum concentration of IL-2.

[1]  E. Vonderheid,et al.  Increased serum concentration of the soluble interleukin-2 receptor in cutaneous T-cell lymphoma. Clinical and prognostic implications. , 1996, Archives of dermatology.

[2]  D. Raulet,et al.  Natural killer cell receptors: The offs and ons of NK cell recognition , 1995, Cell.

[3]  E. Gelfand,et al.  Functional interleukin-2 receptors are expressed on natural killer-like leukemic cells from a dog with cutaneous lymphoma. , 1995, Blood.

[4]  Eric O Long,et al.  Peptide specificity in the recognition of MHC class I by natural killer cell clones , 1995, Science.

[5]  O. Majdic,et al.  Flow cytometric analysis of cell-surface and intracellular antigens in leukemia diagnosis. , 1994, Cytometry.

[6]  K. Imai,et al.  High expression of CD56 (N‐CAM) in a patient with cutaneous CD4‐positive lymphoma , 1994, American journal of hematology.

[7]  J. Gribben,et al.  Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumor immunity. , 1994, Blood.

[8]  S. Lessin,et al.  Th2 cytokine mRNA expression in skin in cutaneous T-cell lymphoma. , 1994, The Journal of investigative dermatology.

[9]  A. Sharpe,et al.  The ikaros gene is required for the development of all lymphoid lineages , 1994, Cell.

[10]  J. Ben-Ezra,et al.  CD3+, CD56+ aggressive variant of large granular lymphocyte leukemia. , 1994, Blood.

[11]  R. Hruban,et al.  Immunohistochemical expression of CD68 antigen in human peripheral blood T cells. , 1994, Human pathology.

[12]  M. Nagarkatti,et al.  Constitutive activation of the interleukin 2 gene in the induction of spontaneous in vitro transformation and tumorigenicity of T cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[13]  J. Earle,et al.  Polymorphic reticulosis: a reappraisal. , 1994, Human pathology.

[14]  M. Wasik,et al.  Constitutive secretion of soluble interleukin-2 receptor by human T cell lymphoma xenografted into SCID mice. Correlation of tumor volume with concentration of tumor-derived soluble interleukin-2 receptor in body fluids of the host mice. , 1994, The American journal of pathology.

[15]  M. Kikuchi,et al.  Expression of adult and fetal natural killer cell markers in sinonasal lymphomas. , 1994, Blood.

[16]  P. Gaulard,et al.  Presence of Epstein-Barr virus in extranodal T-cell lymphomas: differences in relation to site. , 1994, Blood.

[17]  M. Goldman,et al.  Brief report: clonal proliferation of type 2 helper T cells in a man with the hypereosinophilic syndrome. , 1994, The New England journal of medicine.

[18]  A. Tsapis,et al.  Extensive small intestinal T‐cell lymphoma of low‐grade malignancy associated with a new chromosomal translocation , 1994, Cancer.

[19]  W. Paul,et al.  Lymphocyte responses and cytokines , 1994, Cell.

[20]  S. Romagnani.  Lymphokine production by human T cells in disease states. , 1994, Annual review of immunology.

[21]  A. Carbone,et al.  KP1 (CD68)-positive large cell lymphomas: a histopathologic and immunophenotypic characterization of 12 cases. , 1993, Human pathology.

[22]  R. Dummer,et al.  Peripheral blood mononuclear cells in patients with nonleukemic cutaneous T-cell lymphoma. Reduced proliferation and preferential secretion of a T helper-2-like cytokine pattern on stimulation. , 1993, Archives of dermatology.

[23]  D. Simmons,et al.  Molecular cloning of CD68, a human macrophage marker related to lysosomal glycoproteins. , 1993, Blood.

[24]  F. Behm,et al.  Distinctive immunophenotypic features of t(8;21)(q22;q22) acute myeloblastic leukemia in children. , 1992, Blood.

[25]  Kin Fai Ellick Wong,et al.  NCAM (CD56)-positive malignant lymphoma [letter; comment] , 1992 .

[26]  J. Chan,et al.  NCAM (CD56)-positive malignant lymphoma. , 1992, Blood.

[27]  A. Rook,et al.  Aberrant cytokine production by Sezary syndrome patients: cytokine secretion pattern resembles murine Th2 cells. , 1992, The Journal of investigative dermatology.

[28]  J. Chan,et al.  CD56 (NKH1)-positive hematolymphoid malignancies: an aggressive neoplasm featuring frequent cutaneous/mucosal involvement, cytoplasmic azurophilic granules, and angiocentricity. , 1992, Human pathology.

[29]  J. Kant,et al.  In situ hybridization for Epstein-Barr virus NotI repeats in posttransplant lymphoproliferative disorder. , 1992, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[30]  T. Grogan,et al.  Neural cell adhesion molecule-positive peripheral T-cell lymphoma: a rare variant with a propensity for unusual sites of involvement. , 1992, Blood.

[31]  L. Lanier,et al.  Ontogeny of human natural killer (NK) cells: fetal NK cells mediate cytolytic function and express cytoplasmic CD3 epsilon,delta proteins , 1992, The Journal of experimental medicine.

[32]  R. Dummer,et al.  A subcutaneous delta-positive T-cell lymphoma that produces interferon gamma. , 1991, The New England journal of medicine.

[33]  N. Harris.  Pathology of malignant lymphomas , 1991, Current opinion in oncology.

[34]  P. Wiernik,et al.  Neoplastic Diseases of the Blood , 1991 .

[35]  G. Trinchieri,et al.  Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers , 1991, The Journal of experimental medicine.

[36]  S. Hibi,et al.  CYTOKINES IN HAEMOPHAGOCYTIC SYNDROME , 1991 .

[37]  D. Novick,et al.  Monoclonal antibodies to the soluble human IL-6 receptor: affinity purification, ELISA, and inhibition of ligand binding. , 1991, Hybridoma.

[38]  T. Grogan,et al.  Plasma cells in multiple myeloma express a natural killer cell- associated antigen: CD56 (NKH-1; Leu-19) , 1990 .

[39]  R. Warnke,et al.  CD30‐positive large cell lymphomas (‘Ki‐1 lymphoma’) are associated with a chromosomal translocation involving 5q35 , 1990, British journal of haematology.

[40]  R. Warnke,et al.  Diagnosis of myelomonocytic and macrophage neoplasms in routinely processed tissue biopsies with monoclonal antibody KP1. , 1989, The American journal of pathology.

[41]  H. Karasuyama,et al.  Autocrine growth and tumorigenicity of interleukin 2-dependent helper T cells transfected with IL-2 gene , 1989, The Journal of experimental medicine.

[42]  M. Kadin,et al.  Improved detection of lymphoid cell surface antigens in tissues fixed in periodate-lysine-paraformaldehyde (PLP). , 1987, American journal of clinical pathology.

[43]  T. Taniguchi,et al.  Retroviral expression of the human IL‐2 gene in a murine T cell line results in cell growth autonomy and tumorigenicity. , 1987, The EMBO journal.

[44]  F. Milgrom,et al.  Enzyme immunoassay with cell suspensions: studies on reactions between serum antibodies and cell-surface antigens. , 1986, International archives of allergy and applied immunology.